Key Takeaways Although a lot of data exists about using GLP-1 medications to treat diabetes, there isnt as much data yet supporting their long-term use for obesity
Multiple studies, usually done during endoscopies (EGDs) with or without colonoscopies, have shown that patients on GLP-1 receptor agonists have residual gastric contents when fasting from solids for 8 hours (70% of patients, n=10) and when fasting from solids for up to 16 hours (13.1% after 10 hr, n=84
Tune in: Find Good Health, Better World wherever you listen to podcasts
They are solutions for different problems
However, under oxidative stress conditions, Nrf2 dissociates from Keap1, accumulates in the cytoplasm, and is transported into the nucleus to bind to target genes